USDA Announces Framework for Shoring Up the Food Supply Chain and Transforming the Food System to Be Fairer, More Competitive, More Resilient

Via Peters

USDA efforts to create more and better markets will benefit both producers and American consumers through fairer prices, as well as address longstanding issues intensified by pandemic WASHINGTON, June 1, 2022 – Today, the U.S. Department of Agriculture (USDA) is announcing details of a framework to transform the food system […]

FIGO announces a workshop for the sustainable implementation of vaccination programmes for women

Via Peters

This workshop aims to identify specific barriers to the implementation of current World Health Organization (WHO) guidelines on vaccination programmes for women, including the WHO 2020 Global Strategy for the Elimination of Cervical Cancer.   Delegates are invited to share diverse experiences of in-country implementation of both HPV vaccine and other […]

AstraZeneca Announces Positive Results for Enhertu in Treating HER2 Breast Cancer

Via Peters

Trastuzumab deruxtecan demonstrated clinically meaningful and statistically significant improvements in overall and progression-free survival, the company says. AstraZeneca announced positive results from the DESTINY-Breast04 phase 3 trial of trastuzumab deruxtecan (Enhertu, AstraZeneca, Daiichi Sankyo) in individuals with HER2-low unresectable and/or metastatic breast cancer, regardless of hormone receptor (HR) status versus […]

Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App

Via Peters

First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems SAN DIEGO–(BUSINESS WIRE)– Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of bolus insulin dosing on the t:slim X2 insulin pump […]

Petros Pharmaceuticals Announces $7.5 Million Offering

Via Peters

  NEW YORK, Dec. 22, 2021 /PRNewswire/ — Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced that it has entered into definitive agreements with the company’s largest investor and other existing investors, for the purchase and sale of 2,186,589 shares of Petros Pharmaceuticals’ common […]